NGT BioPharma Consultants

Quality & Compliance

“If you think compliance is expensive – try non-compliance.”
– Paul McNutty, Former U.S. Deputy Attorney General

It’s not uncommon for small biotech and biopharmaceutical companies to overlook, or not fully comprehend, the vital importance of Quality & Compliance when formulating their drug development plans and budgets.

The International Conference on Harmonization (ICH) Industry guidance recommends that serious consideration be given to Quality Assurance (QA) very early in the process. Companies that do not pay proper attention to Quality run the risk of downstream consequences such as delayed study starts and product approvals due to regulatory agency actions (e.g., clinical study holds, FDA 483s, Warning Letters etc.).

Services

NGT BioPharma Consultants’ experienced Quality & Compliance team provides expertise supporting the full range of global regulatory compliance requirements. They work seamlessly with other functional areas within our diverse consulting group, including e.g., CMC, Nonclinical Development, Clinical Development, and Regulatory, to provide services that include, but are not limited to the following:
Quality & Compliance service by NGT BioPharma Consultants
Quality & Compliance services

Get in touch

For additional information pertaining to the Quality & Compliance service area, please contact Ronay LeBlanc or our CEO Michael O'Brien via the contact information provided below. Alternatively, please fill out the New Inquiry form and we will get back to you within 48 hours.

Ronay LeBlanc, MA

Ronay LeBlanc, MA

Quality & Compliance

Michael K. O’Brien, PhD

Michael K. O’Brien, PhD

President & CEO

New Inquiry

Inquiry Details